{"id":"https://openalex.org/W2155114669","doi":null,"title":"Evaluating Intended and Unintended Consequences of Health Policy and Regulation in Vulnerable Populations","display_name":"Evaluating Intended and Unintended Consequences of Health Policy and Regulation in Vulnerable Populations","publication_year":2013,"publication_date":"2013-03-18","ids":{"openalex":"https://openalex.org/W2155114669","mag":"2155114669"},"language":"en","primary_location":{"id":"pmh:oai:dash.harvard.edu:1/10423843","doi":null,"is_oa":true,"landing_page_url":"http://nrs.harvard.edu/urn-3:HUL.InstRepos:10423843","pdf_url":"http://nrs.harvard.edu/urn-3:HUL.InstRepos:10423843","source":{"id":"https://openalex.org/S4306401540","display_name":"Digital Access to Scholarship at Harvard (DASH) (Harvard University)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I136199984","host_organization_name":"Harvard University","host_organization_lineage":["https://openalex.org/I136199984"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"Thesis or Dissertation"},"volume":null,"type":"dissertation","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"http://nrs.harvard.edu/urn-3:HUL.InstRepos:10423843","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5031437364","display_name":"Meredith J. Chace","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Meredith J. Chace","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":["https://openalex.org/A5031437364"],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":true,"cited_by_count":1,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10391","display_name":"Healthcare Policy and Management","score":0.8715999722480774,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},"topics":[{"id":"https://openalex.org/T10391","display_name":"Healthcare Policy and Management","score":0.8715999722480774,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T11792","display_name":"Pharmaceutical Economics and Policy","score":0.12479999661445618,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T11649","display_name":"Pharmaceutical industry and healthcare","score":0.000699999975040555,"subfield":{"id":"https://openalex.org/subfields/2910","display_name":"Issues, ethics and legal aspects"},"field":{"id":"https://openalex.org/fields/29","display_name":"Nursing"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/gabapentin","display_name":"gabapentin","score":0.8569999933242798},{"id":"https://openalex.org/keywords/antiepileptic-drugs","display_name":"antiepileptic drugs","score":0.9179999828338623},{"id":"https://openalex.org/keywords/bipolar-disorder","display_name":"bipolar disorder","score":0.8840000033378601},{"id":"https://openalex.org/keywords/media-coverage","display_name":"media coverage","score":0.5460000038146973},{"id":"https://openalex.org/keywords/medication-use","display_name":"medication use","score":0.4429999887943268},{"id":"https://openalex.org/keywords/prescription-drug-spending","display_name":"prescription drug spending","score":0.7929999828338623},{"id":"https://openalex.org/keywords/medicare-part-d","display_name":"Medicare Part D","score":0.6779999732971191},{"id":"https://openalex.org/keywords/out-of-pocket-costs","display_name":"out-of-pocket costs","score":0.8259999752044678},{"id":"https://openalex.org/keywords/drug-regulation","display_name":"drug regulation","score":0.6769999861717224},{"id":"https://openalex.org/keywords/vulnerable-populations","display_name":"vulnerable populations","score":0.7889999747276306}],"concepts":[{"id":"https://openalex.org/C2777134139","wikidata":"https://www.wikidata.org/wiki/Q697327","display_name":"Lawsuit","level":2,"score":0.8122687339782715},{"id":"https://openalex.org/C2776534028","wikidata":"https://www.wikidata.org/wiki/Q1141363","display_name":"Medicaid","level":3,"score":0.7150269746780396},{"id":"https://openalex.org/C2776608144","wikidata":"https://www.wikidata.org/wiki/Q410352","display_name":"Gabapentin","level":3,"score":0.6598890423774719},{"id":"https://openalex.org/C2776889888","wikidata":"https://www.wikidata.org/wiki/Q1135789","display_name":"Unintended consequences","level":2,"score":0.5692176222801208},{"id":"https://openalex.org/C144133560","wikidata":"https://www.wikidata.org/wiki/Q4830453","display_name":"Business","level":0,"score":0.4334115982055664},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4264484941959381},{"id":"https://openalex.org/C162118730","wikidata":"https://www.wikidata.org/wiki/Q1128453","display_name":"Actuarial science","level":1,"score":0.4005151093006134},{"id":"https://openalex.org/C512399662","wikidata":"https://www.wikidata.org/wiki/Q3505712","display_name":"Family medicine","level":1,"score":0.35591262578964233},{"id":"https://openalex.org/C99454951","wikidata":"https://www.wikidata.org/wiki/Q932068","display_name":"Environmental health","level":1,"score":0.3537418842315674},{"id":"https://openalex.org/C100001284","wikidata":"https://www.wikidata.org/wiki/Q2248246","display_name":"Public economics","level":1,"score":0.3328459858894348},{"id":"https://openalex.org/C162853370","wikidata":"https://www.wikidata.org/wiki/Q39809","display_name":"Marketing","level":1,"score":0.32756704092025757},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.27171608805656433},{"id":"https://openalex.org/C17744445","wikidata":"https://www.wikidata.org/wiki/Q36442","display_name":"Political science","level":0,"score":0.22175219655036926},{"id":"https://openalex.org/C160735492","wikidata":"https://www.wikidata.org/wiki/Q31207","display_name":"Health care","level":2,"score":0.1644822657108307},{"id":"https://openalex.org/C162324750","wikidata":"https://www.wikidata.org/wiki/Q8134","display_name":"Economics","level":0,"score":0.1491844654083252},{"id":"https://openalex.org/C199539241","wikidata":"https://www.wikidata.org/wiki/Q7748","display_name":"Law","level":1,"score":0.11072111129760742},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0}],"mesh":[],"locations_count":2,"locations":[{"id":"pmh:oai:dash.harvard.edu:1/10423843","doi":null,"is_oa":true,"landing_page_url":"http://nrs.harvard.edu/urn-3:HUL.InstRepos:10423843","pdf_url":"http://nrs.harvard.edu/urn-3:HUL.InstRepos:10423843","source":{"id":"https://openalex.org/S4306401540","display_name":"Digital Access to Scholarship at Harvard (DASH) (Harvard University)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I136199984","host_organization_name":"Harvard University","host_organization_lineage":["https://openalex.org/I136199984"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"Thesis or Dissertation"},{"id":"mag:2155114669","doi":null,"is_oa":false,"landing_page_url":"https://dash.harvard.edu/bitstream/handle/1/10423843/Chace_gsas.harvard_0084L_10725.pdf?sequence=1","pdf_url":null,"source":null,"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":null}],"best_oa_location":{"id":"pmh:oai:dash.harvard.edu:1/10423843","doi":null,"is_oa":true,"landing_page_url":"http://nrs.harvard.edu/urn-3:HUL.InstRepos:10423843","pdf_url":"http://nrs.harvard.edu/urn-3:HUL.InstRepos:10423843","source":{"id":"https://openalex.org/S4306401540","display_name":"Digital Access to Scholarship at Harvard (DASH) (Harvard University)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I136199984","host_organization_name":"Harvard University","host_organization_lineage":["https://openalex.org/I136199984"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"Thesis or Dissertation"},"sustainable_development_goals":[{"score":0.9074000120162964,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Observational Study","id":"https://openalex.org/study-designs/observational-study"}],"awards":[],"funders":[{"id":"https://openalex.org/F4320306161","display_name":"National Multiple Sclerosis Society","ror":"https://ror.org/03019wv17"},{"id":"https://openalex.org/F4320309622","display_name":"Harvard University","ror":"https://ror.org/03vek6s52"},{"id":"https://openalex.org/F4320320084","display_name":"Multiple Sclerosis Society","ror":"https://ror.org/043fwdk81"},{"id":"https://openalex.org/F4320332177","display_name":"Agency for Healthcare Research and Quality","ror":"https://ror.org/03jmfdf59"},{"id":"https://openalex.org/F4320334272","display_name":"Graduate School of Arts and Sciences, Harvard University","ror":null}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2155114669.pdf","grobid_xml":"https://content.openalex.org/works/W2155114669.grobid-xml"},"referenced_works_count":29,"referenced_works":["https://openalex.org/W24617299","https://openalex.org/W1504844507","https://openalex.org/W1969010569","https://openalex.org/W1969099709","https://openalex.org/W1972504730","https://openalex.org/W1975970108","https://openalex.org/W1989158256","https://openalex.org/W1999793173","https://openalex.org/W2002567615","https://openalex.org/W2026661041","https://openalex.org/W2028281254","https://openalex.org/W2044648026","https://openalex.org/W2046779437","https://openalex.org/W2058062543","https://openalex.org/W2070710669","https://openalex.org/W2075180841","https://openalex.org/W2108553564","https://openalex.org/W2112810026","https://openalex.org/W2114465392","https://openalex.org/W2132852151","https://openalex.org/W2140201003","https://openalex.org/W2160900369","https://openalex.org/W2161185050","https://openalex.org/W2162271060","https://openalex.org/W2167985113","https://openalex.org/W2168472016","https://openalex.org/W2491508873","https://openalex.org/W2890298676","https://openalex.org/W3022868799"],"related_works":["https://openalex.org/W2890282038","https://openalex.org/W2894224650","https://openalex.org/W2479217638","https://openalex.org/W4301367401","https://openalex.org/W2051973088","https://openalex.org/W2015279061","https://openalex.org/W1496408443","https://openalex.org/W1766020230","https://openalex.org/W2125067104","https://openalex.org/W126124053"],"abstract_inverted_index":{"The":[0,30],"objective":[1],"of":[2,12,32,38,83,106,110,133,171,186],"this":[3,78],"dissertation":[4],"is":[5],"to":[6,53,136,160,206,222],"evaluate":[7,54],"whether":[8,182],"two":[9],"different":[10],"types":[11],"policy":[13],"interventions":[14],"in":[15,43,103,119,184,195,231],"the":[16,93,145],"United":[17],"States":[18],"are":[19,175],"associated":[20,191],"with":[21,87,100,192,237],"health":[22],"service":[23],"utilization":[24,66,197],"and":[25,49,60,67,95,112,115,198],"economic":[26],"outcomes.":[27],"Paper":[28,124],"1:":[29],"number":[31],"government":[33],"lawsuits":[34],"accusing":[35],"pharmaceutical":[36],"companies":[37],"off-label":[39,57],"marketing":[40,58],"has":[41],"risen":[42],"recent":[44],"years.":[45],"We":[46],"use":[47],"Medicare":[48,126,134,172],"Medicaid":[50,155,187],"claims":[51],"data":[52],"how":[55,144],"an":[56],"lawsuit":[59,94],"its":[61],"accompanying":[62,96],"media":[63,97],"coverage":[64,98,153],"affected":[65],"spending":[68,121,200],"on":[69,122],"gabapentin":[70],"as":[71,73],"well":[72],"other":[74],"anticonvulsant":[75],"medications.":[76],"In":[77],"interrupted":[79],"time":[80],"series":[81],"analysis":[82],"dual":[84],"eligible":[85,147,177],"patients":[86],"bipolar":[88],"disorder,":[89],"we":[90,180],"found":[91],"that":[92,174,212],"corresponded":[99],"a":[101,108,116,130,165,217,227,243],"decrease":[102],"market":[104],"share":[105],"gabapentin,":[107],"substitution":[109],"newer":[111],"expensive":[113],"anticonvulsants,":[114],"substantial":[117],"increase":[118,230],"overall":[120],"anticonvulsants.":[123],"2:":[125],"Part":[127,161,207,223],"D":[128,162,224],"was":[129],"major":[131],"expansion":[132],"benefits":[135,189],"cover":[137],"pharmaceuticals.":[138],"There":[139],"were":[140,190],"initial":[141],"concerns":[142],"about":[143],"dually":[146,176],"population":[148],"who":[149,214,239],"previously":[150,215],"had":[151],"drug":[152,188,196,219,234],"through":[154],"would":[156],"fare":[157],"after":[158,203],"transitioning":[159],"plans.":[163],"Using":[164],"nationally":[166],"representative":[167],"longitudinal":[168],"panel":[169],"survey":[170],"Beneficiaries":[173],"for":[178,201],"Medicaid,":[179],"investigated":[181],"differences":[183],"generosity":[185],"differential":[193],"changes":[194],"out-of-pocket":[199],"duals":[202],"they":[204],"transitioned":[205],"D.":[208],"Our":[209],"finding":[210],"suggest":[211],"those":[213,238],"encountered":[216],"monthly":[218],"cap":[220],"prior":[221],"implementation":[225],"experienced":[226],"differentially":[228],"higher":[229],"annual":[232],"prescription":[233],"fills":[235],"compared":[236],"did":[240],"not":[241],"face":[242],"cap.":[244]},"counts_by_year":[{"year":2017,"cited_by_count":1}],"updated_date":"2026-09-26T08:19:03.415552","created_date":"2016-06-24T00:00:00"}